Lack of subsensitivity to mizolastine over 8-week treatment

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 4, 1996, Pages 251-256

  Bousquet, J ^a   Chanal, I ^a   Murrieta, M ^b   Stalla Bourdillon, A ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b SANOFI   (France)

Author keywords

histamine 1 receptor antagonist; mizolastine; placebo; prick skin test; subsensitivity

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CODEINE PHOSPHATE; HISTAMINE AGONIST; MIZOLASTINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URTICARIA;

EID: 0029979123     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb00076.x     Document Type: Article

References (20)

1. Monash S. Development of refractory condition of skin towards antihistamine drugs after antihistaminic therapy as determined by histamine iontophoresis. J Invest Dermatol 1950;15:1-12.
2. Dannenberg TB, Feinberg SM. The development of tolerance to antihistamines. J Allergy 1951;22:330-9.
3. Taylor RJ, Long WF, Nelson HS. The development of subsensitivity to chlorpheniramine. J Allergy Clin Immunol 1985;76:103-7.
4. Bantz EW, Dolen WK, Chadwick EW, Nelson HS. Chronic chlorpheniramine therapy: subsensitivity, drug metabolism, and compliance. Ann Allergy 1987;59:341-6.
5. Long WF, Taylor RJ, Leavengood DC, Nelson HS. Skin test suppression by antihistamines and the development of subsensitivity. J Allergy Clin Immunol 1984;76:113-17.
6. Roman IJ, Kassem N, Gural RP, Herron J. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man. Ann Allergy 1986;57:253-6.
7. Bousquet J, Chanal I, Skassa-Brociek W, Lemonier C, Michel FB. Lack of subsensitivity to loratadine during long-term dosing during 12 weeks. J Allergy Clin Immunol 1990;86:248-53.
8. Simons FER, Watson WTA, Simons KJ. Lack of subsensitivity to terfenadine during long-term terfenadine treatment. J Allergy Clin Immunol 1988;82:1068-75.
9. Rihoux JP, Ghys L, Muhlethaler K, Wüthrich B. The skin as a target organ for the investigation of antiallergic drugs: comparison between cetirizine and terfenadine. Pharmacol Treat 1992;184:111-15.
10. Watson WTA, Simons KJ, Chen XY, Simons FER. Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:457-64.
11. Rosenzweig P, Guillaume M, Brohier S, Ulliac N, Cabanis MJ, Thebault JJ. Comparative wheal and flare study of mizolastine versus terfenadine, cetirizine, loratadine and placebo in healthy volunteers. Br J Clin Pharmacol 1995; 40:459-65.
12. Vuurman P, Rosenzweig P, O'Hanlon JF. Mizolastine's effects on psychomotor and actual driving performance in healthy volunteers after single 5, 10, 20 and 40 mg doses vs. clemastine 2 mg and placebo. Eur J Allergy Clin Immunol 1993;48(16):30.
13. Kerr JS, Dunmore C, Hindmarch I. The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers. Eur J Clin Pharmacol 1994;47:331-5.
14. 1-antagonist SL 85.0324 vs placebo and dimetinden in volunteers. Eur J Pharmacol 1990;183:593-4.
15. Patat A, Gram LF, Dubrue C, Brohier S, Cabanis MJ, Rosenzweig P. Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Int Clin Psychopharmacol 1994;9:101-8.
16. 1 antihistamine. Ann Allergy 1992;69:135-9.
17. Stern MA, Dunmore CJ, Theron M. A double-blind comparative study of mizolastine 10 mg and placebo in the treatment of seasonal allergic rhinoconjunctivitis in adult patients. Eur J Allergy Clin Immunol 1992;47 Suppl 12:177.
18. Simons FER, McMillan JL, Simons KJ. A double-blind, single-dose, cross-over comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-7.
19. van Arsdel PP, Larson EB. Diagnostic tests for patients with suspected allergic disease. Ann Intern Med 1989;110:304-12.
20. Byrom H, Clark M, White V, Vere DW. The basis of the histamine assay in skin. Br J Clin Pharmacol 1991;32:367-70.